NCT06006637 Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder
| NCT ID | NCT06006637 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State University of New York - Upstate Medical University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-10-17 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2023-10-17 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will consist of a randomized, double-blind, sham-controlled clinical trial at SUNY Upstate Medical University and Mt. Sinai Medical Center with 80 autistic children evaluating the effects of transcranial photobiomodulation (tPBM) on multiple clinically validated scales.
Eligibility Criteria
Inclusion Criteria: * Ages 2 - 8 * Autism spectrum disorder diagnosis * CARS-2 score of 30 - 45 Exclusion Criteria: * CARS scores less than 30 or over 45. * Taking psychotropic medications. * Having skin lesions on scalp * Having history of seizures * Having history of abnormal EEG * Being a relative of the PI or a researcher * Having implanted devices (including cochlear implants).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06006637 clinical trial?
This trial is open to participants of all sexes, aged 2 Years or older, up to 8 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06006637 currently recruiting?
Yes, NCT06006637 is actively recruiting participants. Contact the research team at sullivaw@upstate.edu for enrollment information.
Where is the NCT06006637 trial being conducted?
This trial is being conducted at New York, United States, Syracuse, United States.
Who is sponsoring the NCT06006637 clinical trial?
NCT06006637 is sponsored by State University of New York - Upstate Medical University. The trial plans to enroll 80 participants.